Literature DB >> 3703528

Temporal arteritis. A clinicopathologic study.

P J McDonnell, G W Moore, N R Miller, G M Hutchins, W R Green.   

Abstract

Clinical and laboratory findings of 237 consecutive patients who had 250 temporal artery biopsies performed at the Wilmer Institute during a 15-year period were reviewed. Biopsies were reviewed independently on three separate occasions by four observers who, unaware of the clinical history, made one of the following histopathologic diagnoses: active arteritis, healed arteritis, arteriosclerosis, atherosclerosis, normal, or other. Biopsies were reviewed a fourth time by the observers together to establish a consensus diagnosis. The frequency of intraobserver disagreement in biopsy interpretation ranged from 4.4 to 25.6% of cases. The frequency with which observers disagreed with the consensus diagnosis (interobserver variation) ranged from 4.3 to 13.5% of cases. Pre-biopsy steroid therapy for seven to eight weeks or longer was associated with loss of the histopathologic features of active arteritis. We recommend biopsies for all patients with known contraindications to steroid therapy. In addition, multivariant regression analysis suggests that certain patients can be selected who are likely to have positive biopsies. For some patients, the clinical diagnosis of temporal arteritis can be based on the clinical signs and symptoms and their response to a therapeutic trial of steroids.

Entities:  

Mesh:

Year:  1986        PMID: 3703528     DOI: 10.1016/s0161-6420(86)33706-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  17 in total

1.  Temporal artery biopsy: is there any value in examining biopsies at multiple levels?

Authors:  A Chakrabarty; A J Franks
Journal:  J Clin Pathol       Date:  2000-02       Impact factor: 3.411

2.  Ophthaproblem. Anterior ischemic optic neuropathy.

Authors:  S Sharma
Journal:  Can Fam Physician       Date:  1999-07       Impact factor: 3.275

3.  Clinical course and management of a consecutive series of patients with "healed temporal arteritis".

Authors:  Yvonne C Lee; Robert F Padera; Erika H Noss; Anne H Fossel; Don Bienfang; Matthew H Liang; William P Docken
Journal:  J Rheumatol       Date:  2011-12-01       Impact factor: 4.666

4.  Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better?

Authors:  A Mahr; M Saba; M Kambouchner; M Polivka; M Baudrimont; I Brochériou; J Coste; L Guillevin
Journal:  Ann Rheum Dis       Date:  2006-06       Impact factor: 19.103

5.  [Giant cell arteritis: etiological knowledge and diagnostic challenge for pathologists].

Authors:  S C Schaefer; H A Lehr
Journal:  Pathologe       Date:  2012-05       Impact factor: 1.011

6.  Histological parameters helpful in recognising steroid-treated temporal arteritis: an analysis of 35 cases.

Authors:  Ramon L Font; Venkatesh C Prabhakaran
Journal:  Br J Ophthalmol       Date:  2006-09-20       Impact factor: 4.638

7.  Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease. Groupe de Recherche sur l'Artérite à Cellules Géantes.

Authors:  P Duhaut; L Pinède; H Bornet; S Demolombe-Ragué; C Dumontet; J Ninet; R Loire; J Pasquier
Journal:  Ann Rheum Dis       Date:  1999-06       Impact factor: 19.103

8.  Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis.

Authors:  N Ray-Chaudhuri; D Ah Kiné; S O Tijani; D V Parums; N Cartlidge; N P Strong; M R Dayan
Journal:  Br J Ophthalmol       Date:  2002-05       Impact factor: 4.638

9.  Necrosis of choroidal melanoma: in ciliary artery involvement with temporal arteritis.

Authors:  J R Wolter
Journal:  Br J Ophthalmol       Date:  1989-03       Impact factor: 4.638

10.  Clinicopathologic correlations in giant cell arteritis: a retrospective study of 107 cases.

Authors:  Ling Zhou; Katie Luneau; Cornelia M Weyand; Valérie Biousse; Nancy J Newman; Hans E Grossniklaus
Journal:  Ophthalmology       Date:  2009-06-04       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.